printedon1/5/2018 printedon1/5/2018 - clinicaltrials.gov · coleman et al clarithromvcin has an...

6

Printed on 1/5/2018 Printed on 1/5/2018 Printed on 1/5/2018 Printed on 1/5/2018

Upload: others

Post on 23-May-2020

2 views

Category:

Documents

0 download

Report

Download

Embed Size (px):

TRANSCRIPT

Page 1: Printedon1/5/2018 Printedon1/5/2018 - ClinicalTrials.gov · Coleman et al Clarithromvcin has an additive effect when combined with immunomodulatory molecules and steroids by increasing

Printed on 1/5/2018 Printed on 1/5/2018

Printed on 1/5/2018 Printed on 1/5/2018

Page 2: Printedon1/5/2018 Printedon1/5/2018 - ClinicalTrials.gov · Coleman et al Clarithromvcin has an additive effect when combined with immunomodulatory molecules and steroids by increasing

Printed on 1/5/2018 Printed on 1/5/2018

Printed on 1/5/2018 Printed on 1/5/2018

Page 3: Printedon1/5/2018 Printedon1/5/2018 - ClinicalTrials.gov · Coleman et al Clarithromvcin has an additive effect when combined with immunomodulatory molecules and steroids by increasing

Printed on 1/5/2018 Printed on 1/5/2018

Printed on 1/5/2018 Printed on 1/5/2018

Page 4: Printedon1/5/2018 Printedon1/5/2018 - ClinicalTrials.gov · Coleman et al Clarithromvcin has an additive effect when combined with immunomodulatory molecules and steroids by increasing

Printed on 1/5/2018 Printed on 1/5/2018

Printed on 1/5/2018 Printed on 1/5/2018

Page 5: Printedon1/5/2018 Printedon1/5/2018 - ClinicalTrials.gov · Coleman et al Clarithromvcin has an additive effect when combined with immunomodulatory molecules and steroids by increasing

Printed on 1/5/2018 Printed on 1/5/2018

Printed on 1/5/2018 Printed on 1/5/2018

Page 6: Printedon1/5/2018 Printedon1/5/2018 - ClinicalTrials.gov · Coleman et al Clarithromvcin has an additive effect when combined with immunomodulatory molecules and steroids by increasing

Printed on 1/5/2018 Printed on 1/5/2018

Fibrinogen scaffolds with immunomodulatory properties

STUDY DEVICE: KeraStat Cream - ClinicalTrials.gov · on the study unless the subject requires active treatment with systemic steroids, immune suppression or biologic agents, or systemic

Research Protocol - ClinicalTrials.gov

ClinicalTrials.gov Identifier: NCT02099864

Steroids Steroids Some questions we need answers to Some questions we need answers to What are steroids? What are steroids? Who takes steroids Who takes

Immunomodulatory activity of Bhallatak

REP0114 - clinicaltrials.gov

STEROIDS IN NEUROSURGERY STEROIDS IN NEUROSURGERY

GILEAU - ClinicalTrials.gov

By: Makaila Lambert Steroids. There are many different types of Steroids Injectable Steroids, Steroid Pills, British Dragon Steroids, Cutting Steroids,

NAXIVA - ClinicalTrials.gov

7,7/( 3$*( - ClinicalTrials.gov

Amendment - ClinicalTrials.gov

PPD PPD - ClinicalTrials.gov

$PHQGPHQW - ClinicalTrials.gov

Immunomodulatory leads from medicinal plants

Immunomodulatory and Antiangiogenic Mechanisms of

Titlpage - ClinicalTrials.gov

Schema - ClinicalTrials.gov

Immunotherapy: Novel Immunomodulatory Targets

NCT03244618 PPD - ClinicalTrials.gov

TRICOLOR - clinicaltrials.gov

Immunomodulatory plant

NSAIDs/Nitazoxanide/Azithromycin Immunomodulatory Protocol

SFA ISR - ClinicalTrials.gov

extract with immunomodulatory effects

T NOT - ClinicalTrials.gov

Immunomodulatory therapy for parkinson’s disease

Pharmacokinetics, tissue distribution and immunomodulatory

Immunomodulatory Effects of Intravenous Immunoglobulin

NCT03054870 - clinicaltrials.gov

EWOLUTION - ClinicalTrials.gov

Investigation of immunomodulatory properties of

PRADO - ClinicalTrials.gov

STUDY PROTOCOL - ClinicalTrials.gov